Constitutive expression of bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H- 2b alloantigens
暂无分享,去创建一个
[1] J. Merino,et al. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells. , 1994, Immunology.
[2] L. Ding,et al. Developmental regulation of the Bcl‐2 protein and susceptibility to cell death in B lymphocytes. , 1994, The EMBO journal.
[3] G. J. V. Nossal,et al. Negative selection of lymphocytes , 1994, Cell.
[4] S. Korsmeyer,et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.
[5] T. Honjo,et al. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow , 1993, The Journal of experimental medicine.
[6] V. Stewart,et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. , 1993, Science.
[7] R. Hardy,et al. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver , 1993, The Journal of experimental medicine.
[8] J. Merino,et al. Autoimmune syndrome after induction of neonatal tolerance to I‐E antigens , 1993, European journal of immunology.
[9] M. Cooke,et al. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death , 1993, Cell.
[10] D. Abramowicz,et al. Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. , 1993, Transplantation proceedings.
[11] J C Reed,et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Vaux,et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Korsmeyer,et al. Bcl-2 maintains B cell memory , 1991, Nature.
[14] S. Korsmeyer,et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Schurmans,et al. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens. , 1991, Journal of immunology.
[16] S. Schurmans,et al. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. , 1990, Journal of immunology.
[17] D. Mason,et al. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. , 1990, The American journal of pathology.
[18] M. Gershwin,et al. The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. , 1990, Journal of immunology.
[19] J. Streilein,et al. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. , 1990, Journal of immunology.
[20] S. Izui,et al. Differential effect of the autoimmune yaa and ipr genes on the acceleration of lupus‐like syndrome in mrl/mpj mice , 1989, European journal of immunology.
[21] S. Schurmans,et al. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells. , 1989, Journal of immunology.
[22] S. Izui,et al. Autoantibody repertoire analysis in normal and lupus-prone mice. , 1989, Journal of autoimmunity.
[23] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[24] R. Falk,et al. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.
[25] A. Rolink,et al. The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice , 1987, The Journal of experimental medicine.
[26] G. Nossal,et al. Clonal analysis of the anti-DNA repertoire of murine B lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Lambert,et al. Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation. , 1986, Journal of immunology.
[28] T. H. The,et al. AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.
[29] W. Seaman,et al. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4 , 1985, The Journal of experimental medicine.
[30] A. Theofilopoulos,et al. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus , 1979, The Journal of experimental medicine.
[31] B. Kullgren,et al. Etiology, pathogenesis, and prevention of a fatal host-versus-graft syndrome in parent-F1 mouse chimeras. , 1970, The American journal of pathology.
[32] L. Buelta,et al. Self-limited autoimmune disease related to transient donor B cell activation in mice neonatally injected with semi-allogeneic F1 cells. , 1992, International immunology.
[33] D. Abramowicz,et al. Renal immunopathology in murine host-versus-graft disease. , 1991, Kidney international.
[34] S. Schurmans,et al. Autoimmune syndrome after neonatal induction of tolerance to alloantigens: analysis of the specificity and of the cellular and genetic origin of autoantibodies. , 1991, Autoimmunity.
[35] S. Schurmans,et al. Expression of anti-DNA clonotypes and the role of helper T-lymphocytes during the autoimmune response in mice tolerant to alloantigens. , 1988, Autoimmunity.